PubHive Wins Award for Best Integrated Pharmacovigilance (PV) Literature & Aggregate Safety Reporting Solution

PubHive Ltd., a cloud-based scientific software company, today announced that the company’s software-as-a-service (SaaS) platform PubHive Navigator was voted ‘Best Integrated Pharmacovigilance Literature & Aggregate Safety Reporting Solutions’, a category in the 2022 International Life Sciences Awards program that is produced by the digital magazine Global Health & Pharma (GHP).

As an AI-powered platform, PubHive Navigator optimizes manual processes involving pharmacovigilance (PV) literature and aggregate safety reporting information. Published scientific journal content is an important source of information on suspected adverse reaction case reports and potential safety signals. Relevant literature reviews are aggregated along with other safety-related information from a variety of sources, then included in safety reports that are submitted to regulators on a periodic basis. Reports focus on an overview, assessment of the safety profile and benefit-risk evaluation for post-marketed and pre-marketed products. 

“PubHive is honored to have earned this life science industry award from GHP and to receive recognition of our reputation, commitment, innovation, determination, and contribution to the life science industry,” said Raj Vaghela, President and CEO of PubHive Ltd. “A growing number of companies are discovering just exactly how valuable PubHive’s platform flexibility is for boosting efficiency, oversight, and audit readiness – for PV literature, aggregate safety reporting, plus a number of other mission-critical drug safety and pharmacovigilance functions.” 

Drawing together scientific leaders across the Human, Animal, and Plant Life sectors, the International Life Sciences Awards 2022 recognise the vital work and impressive talent which drives the industry and grows more abundant each year. GHP Magazine’s dedicated research team assesses all information presented during the award nomination process and also gathers information independently from a variety of publicly accessible sources. The research team then casts their final judgment based on various criteria such as great contribution to the global healthcare or pharmaceutical industries, diversification, sustained or continued growth, significant innovations, plus feedback from patients and customers. Launched in 2016, GHP is owned and operated by AI Global Media and is headquartered in the UK.

PubHive Ltd. is a cloud-based software company with a mission to make healthier scientific literature and safety workflows for life science companies across all stages of the commercialization lifecycle – from discovery to post-market. PubHive Navigator™, the company’s scientific workflow management platform, optimizes existing business processes and automates repetitive work for teams in drug safety and pharmacovigilance (DSPV), medical affairs, health economics and outcomes research (HEOR), research and development, regulatory affairs, information management, and other divisions.

To learn more about PubHive and the PubHive Navigator platform, visit the PubHive website at pubhive.com.

About PubHivePubHive Ltd. is a cloud-based software company with a mission to make healthier scientific literature and safety workflows for life science companies across all stages of the commercialization lifecycle – from discovery to post-market. PubHive Navigator, the company’s scientific workflow management platform, optimizes existing business processes and automates repetitive work for teams in drug safety and pharmacovigilance (DSPV), regulatory and medical affairs, health economics and outcomes research (HEOR), research and development, information management, and other divisions. Powered by a proprietary Omni-Loop Artificial Intelligence (AI)™ engine, PubHive Navigator is the only 'fit for purpose' one-stop scientific workflow automation platform today, distinguishing itself through flexible end-to-end workstreams and intuitive interfaces that make literature handling quick and easy.